ML
Michael Lane (Executive Vice President) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in IDEXX Laboratories, Inc. (IDXX). The largest single filing was $2.7M of IDXX (3,979 sh across 3 lots, as filed), executed Nov 4. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.7M
shares × price, as filed
Last traded
Nov 4
Filed Nov 5
Median ADV $321.9M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
IDXXRecent filings
IDXXSALE
IDEXX Laboratories, Inc.
View filing →
$2.7M3,979 sh across 3 lots
Exec Nov 4
Filed Nov 5 · 5:01 PM ET IDXXSALE IDEXX Laboratories, Inc. View filing → $5.3M
8,411 sh across 3 lots
Exec Aug 6 2025
Filed Aug 8 2025 · 5:30 PM ET